Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiota Transplantation in Crohn's Disease After Anti-TNF Withdrawal
NCT04997733Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2021
- Primary completion
- May 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in Crohn's disease (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinical efficacy of FMT versus sham transplantation at 52 weeks. Started Sep 2021; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04997733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04997733.